Henry HebelChief Operating Officer at Aldevron
Henry Hebel is Chief Operating Officer of Aldevron in Fargo, North Dakota, responsible for the company’s strategy and global planning, customer service, procurement, sourcing, supply chain and global operations. Hebel was instrumental in developing the company’s new 70,000 square-foot GMP biologics manufacturing facility in Fargo and is leading the ongoing expansion and development of Aldevron’s new 14-acre corporate campus.
Hebel has more than 25 years of biopharmaceutical manufacturing experience, previously serving as vice-president of operations for Aeglea Biotherapeutics of Austin, Texas. Additionally, as vice-president of drug development for Terapio, also in Austin, he successfully developed a radiation countermeasure product allowing entry into government countermeasure development programs.
Hebel holds a Bachelor of Science in Zoology and an MBA from Texas A&M University in College Station, Texas. He has been awarded multiple patents and dozens of his writings have been published in industry journals.